TWiV 1002: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin\xa0discusses\xa0completeness and spin of\xa0medRxiv preprints and associated published abstracts of COVID-19 randomized clinical trials, lessons learned from a COVID-19 dog screening pilot in California K-12 schools, SARS-CoV-2 reinfection and severity of the disease, effectiveness of COVID-19 bivalent vaccine, Molnupiravir and risk of post-acute sequelae of COVID-19, risk of new-onset long Covid following reinfection with SARS-CoV-2, low vitamin D levels associated with long COVID syndrome in COVID-19 survivors, and clinical experience with the \u03b12A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in \u201cLong-COVID19\u201d.
Click arrow to play Download\xa0TWiV 1002 (27 MB .mp3, 44 min)
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- Completeness and spin\xa0of\xa0medRxiv\xa0preprint and published abstracts of COVID-19 randomized clinical trials (JAMA)
- Lessons learned from a COVID-19\xa0dog screening pilot\xa0(JAMA)
- SARS-CoV-2\xa0reinfection and severity\xa0of the disease (Viruses)
- Effectiveness\xa0of COVID-19 bivalent vaccine (medRxiv)
- Molnupiravir and risk of\xa0post-acute sequelae\xa0of COVID-19 (BMJ)
- Risk\xa0of new-onset long Covid following reinfection with SARS-CoV-2 (medRxiv)
- Low vitamin D levels are associated with Long COVID in\xa0COVID-19 survivors\xa0(JCEM)
- Clinical experience\xa0with the \u03b12A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for treatment of Long-COVID19 (NIH)
- Contribute to our\xa0ASTMH fundraiser at PWB
- Letters read\xa0on TWiV 1002
- Timestamps by\xa0Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv